Ligand profile
ZINC35781317
Virtual-screening candidate from ZINC.
Bound to: KP13_00203 — putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC35781317- UniProt (similar protein)
P22557- Tanimoto
- 0.780
- Target protein
- KP13_00203
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 59.0
- −1 ≤ LogP ≤ 5 0.84
- MW ≤ 500 Da 222.3
- LogP ≤ 5 0.84
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 59.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCn1cc(NC(=O)C2CCNCC2)cn1CCn1cc(NC(=O)C2CCNCC2)cn1
InChI=1S/C11H18N4O/c1-2-15-8-10(7-13-15)14-11(16)9-3-5-12-6-4-9/h7-9,12H,2-6H2,1H3,(H,14,16)InChI=1S/C11H18N4O/c1-2-15-8-10(7-13-15)14-11(16)9-3-5-12-6-4-9/h7-9,12H,2-6H2,1H3,(H,14,16)
QIVHKKOQDOHOLU-UHFFFAOYSA-NQIVHKKOQDOHOLU-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- NUA
- Homolog
- P22557
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC35781317 →
- ZINC ZINC20 ZINC35781317 →
- UniProt UniProt P22557 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC35781317”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00203.
PDB 33
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).